GB

Euan Morrison Wallace

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Euan Morrison Wallace. Retrieved from https://idiyas.com/inventor/euan-morrison-wallace-lttnjoen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Euan Morrison Wallace: Innovator in Genetic Testing

Introduction

Euan Morrison Wallace is a notable inventor based in Great Britain. He has made significant contributions to the field of genetic testing, particularly in the early detection of Down's Syndrome. His innovative methods have the potential to improve prenatal screening processes.

Latest Patents

Euan Morrison Wallace holds a patent for a method of genetic testing that focuses on elevated levels of Inhibin-A in maternal serum or plasma. This method utilizes a monoclonal antibody specific for the Inhibin-A beta sub-unit, along with another monoclonal antibody specific for the Inhibin-A alpha sub-unit. The beta sub-unit antibody captures Inhibin-A from the test sample, while the alpha sub-unit antibody serves as the detection antibody linked to a detectable marker. This assay method is designed to be carried out in the first or second trimester as a screening test to identify patients who may require further diagnostic testing.

Career Highlights

Throughout his career, Euan has worked with prestigious institutions such as Oxford Brookes University and Edinburgh University. His work in these academic environments has allowed him to collaborate with other experts in the field and contribute to advancements in genetic research.

Collaborations

Euan Morrison Wallace has collaborated with Nigel Patrick Groome, further enhancing the impact of his research and innovations in genetic testing.

Conclusion

Euan Morrison Wallace is a key figure in the realm of genetic testing, with a focus on improving prenatal screening methods. His contributions have the potential to significantly impact the early detection of genetic conditions, ultimately benefiting many families.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…